On December 7, under the joint organization of China Pharmaceutical Enterprise Management Association and China Pharmaceutical Enterprise Directors Association, the 18^th China Pharmaceutical Enterprise Marketing Summit Forum was held in Nanchang, Jiangxi province, during which the excellent enterprises and outstanding leaders in China’s medical industry during the 11^th Five-year Plan were announced. YRPG’s new medicine R&D project Dezocine raw material and injection was granted the award of Excellent Medical Technological Innovation Case. The Group’s Deputy Chairman Xu Haoyu and Deputy General Manager Ji Weiqun participated in the forum and accepted medal and certificate.
As a new non-addiction analgesic with powerful effect under YRPG’s independent research and development, dezocine raw material and injection was China’s exclusive variety with proprietary intellectual property rights. It had such merits as low reliance, high safety and effective analgesia, which were recognized by the authoritative experts in China. During the “1^thFive-year Plan, the product was successfully developed and realized industrialization, creating huge economic and social benefits.
The chairman of China Pharmaceutical Enterprise Management Association Yu Mingde and more than 400 national key medical representatives attended the forum. The year 2010 was the last year of China’s 11^th Five-year Plan and a crucial year to promote the continuity of medical health system reform in a comprehensive way. Medical reform will be further deepened, and the 12^th Five-year Plan WAs about to take shape. The forum aimed to systematically summarize the development characteristics presented in China’s medical industry, prospectively discussing and judging the general trend of the operation of China’s medical economics and the overall development trend of industry pattern in the next ten years, establishing the platform for large number of medical enterprises to contact and communicate with and learn from each other, and encouraging the excellent entrepreneurs in medical industry for their distinguished contribution to the development of enterprises and industries.